This website is for participants enrolled in the
TH HSV REC-003 Research Study

a study to test a new immunotherapy for suppressing genital herpes recurrences in adults 18 to 60 years of age.

Learn More

© 2001- 2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

GSK plc. Registered in England and Wales No. 3888792.

Registered office: 79 New Oxford Street, London, United Kingdom, WC1A 1DG.

Privacy policy

Terms of use

Cookie policy

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.